scispace - formally typeset
D

David Eisenberg

Researcher at Technion – Israel Institute of Technology

Publications -  719
Citations -  120468

David Eisenberg is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Amyloid & Protein structure. The author has an hindex of 156, co-authored 697 publications receiving 112460 citations. Previous affiliations of David Eisenberg include Howard Hughes Medical Institute & Hebrew University of Jerusalem.

Papers
More filters
Journal ArticleDOI

Non-proteinaceous hydrolase comprised of a phenylalanine metallo-supramolecular amyloid-like structure.

TL;DR: Evidence is presented for the ability of a single amino acid to self-assemble into a potent and stable catalytic structural entity showing catalytic properties similar to those of the natural enzyme carbonic anhydrase.
Journal ArticleDOI

An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase.

TL;DR: Two crystal structures of M. tuberculosis antigen 85B are determined and a new class of antituberculous drugs are suggested, made by connecting two trehalose molecules by an amphipathic linker, minimizes aqueous exposure of the apolar mycolates.
Journal ArticleDOI

Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta

TL;DR: Structural-activity relationship studies of the fiber-binding compounds and their derivatives suggest that compound binding increases fiber stability and decreases fiber toxicity, perhaps by shifting the equilibrium of Aβ from oligomers to fibers.
Journal ArticleDOI

Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs

TL;DR: Cryo-EM analyses of α-synuclein fibrils formed with hereditary Parkinson's disease mutant H50Q reveal features that help explain the mutant’s properties in vitro and in cells.
Journal ArticleDOI

Structures of the two 3D domain-swapped RNase A trimers.

TL;DR: The first example of a protein that can form both a linear and a cyclic domain‐swapped oligomer is revealed, permit interpretation of the enzymatic activities of the RNase A oligomers on double‐stranded RNA.